Nocira’s WAVE device is the 1st ever FDA-awarded “Breakthrough Device” for treating MIGRAINE – the #1 cause of disability and #4 for all ER visits. Six trials have consistently shown Nocira’s WAVE is FAR more effective and faster acting v/s all other current migraine drugs & devices – and is non-invasive, drug free, easy, and pleasant, with no known significant side effects or contra-indications.
- Home
- 2025
- 2024
- Academy
- Being an Angel Investor
- Blockchain and Crypto
- Building Effective Teams
- Cap Tables
- Cleantech
- Corporate Governance
- Diversity, Equity and Inclusion
- Due Diligence
- Economic Outlook
- Entrepreneurs
- Exits
- Family Office Investing
- Funding Tactics
- Go To Market
- Impact Investing
- Intellectual Property
- Portfolio Diversification
- Risk Management
- Startup Valuation
- Supply Chain
- Tax Academy
- Tech and AI
- Term Sheets
- Testimonials
- Training